Original Contributions |
From the Departments of Physiology and Medicine, University of Toronto and The Toronto Hospital, Toronto, Ontario, Canada.
Correspondence to Dr Peter H. Backx, Department of Medicine, The Toronto Hospital, CCRW 3-802, 101 College St, Toronto, Ontario M5G 2C4, Canada. E-mail p.backx{at}utoronto.ca
AbstractHeart failure is the leading cause of mortality in patients with transfusional iron (Fe) overload in which myocardial iron uptake ensues via a transferrin-independent process. We examined the ability of L-type Ca2+ channel modifiers to alter Fe2+ uptake by isolated rat hearts and ventricular myocytes. Perfusion of rat hearts with 100 nmol/L 59Fe2+ and 5 mmol/L ascorbate resulted in specific 59Fe2+ uptake of 20.4±1.9 ng of Fe per gram dry wt. Abolishing myocardial electrical excitability with 20 mmol/L KCl reduced specific 59Fe2+ uptake by 60±7% (P<0.01), which suggested that a component of myocardial Fe2+ uptake depends on membrane voltage. Accordingly, 59Fe2+ uptake was inhibited by 10 µmol/L nifedipine (45±12%, P<0.02) and 100 µmol/L Cd2+ (86±3%; P<0.001) while being augmented by 100 nmol/L Bay K 8644 (61±18%, P<0.01) or 100 nmol/L isoproterenol (40±12%, P<0.05). By contrast, uptake of 100 nmol/L ferric iron (59Fe3+) was significantly lower (1.4±0.3 ng Fe per gram dry wt; P<0.001) compared with divalent iron. These data suggest that a component of Fe2+ uptake into heart occurs via the L-type Ca2+ channel in myocytes. To investigate this further, the effects of Fe2+ on cardiac myocyte L-type Ca2+ currents were measured. In the absence of Ca2+, noninactivating nitrendipine-sensitive Fe2+ currents were recorded with 15 mmol/L [Fe2+]o. Low concentrations of Fe2+ enhanced Ca2+ current amplitude and slowed inactivation rates, which was consistent with Fe2+ entry into the cell, whereas higher Fe2+ levels caused dose-dependent decreases in peak current. Fe3+ had no effect on current amplitude or decay. Combined, our data suggest that myocardial Fe2+ uptake occurs via L-type Ca2+ channels and that blockade of these channels might be useful in the treatment of patients with excessive serum iron levels.
Key Words: iron overload channels heart failure permeability Ca2+
This article has been cited by other articles:
![]() |
H. Glickstein, R. B. El, G. Link, W. Breuer, A. M. Konijn, C. Hershko, H. Nick, and Z. I. Cabantchik Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences Blood, November 1, 2006; 108(9): 3195 - 3203. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Heilig, K. J. Thompson, R. M. Molina, A. R. Ivanov, J. D. Brain, and M. Wessling-Resnick Manganese and iron transport across pulmonary epithelium Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1247 - L1259. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Donovan, C. N. Roy, and N. C. Andrews The Ins and Outs of Iron Homeostasis Physiology, April 1, 2006; 21(2): 115 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Y. Oudit, M. G. Trivieri, N. Khaper, T. Husain, G. J. Wilson, P. Liu, M. J. Sole, and P. H. Backx Taurine Supplementation Reduces Oxidative Stress and Improves Cardiovascular Function in an Iron-Overload Murine Model Circulation, April 20, 2004; 109(15): 1877 - 1885. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |